Outcome after surgical treatment of gastrointestinal stromal tumors

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 6-7, 2007, Pages 579-584

  Weber, Anne Géraldine ^a   Jovenin, Nicolas ^a   Lubrano, Denis ^a   Journu, Jérome ^a   Yaziji, Nallah ^a   Bouche, Olivier ^a   Diebold, Marie Danièle ^a   Delattre, Jean François ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER INVASION; CANCER SURGERY; CELL COUNT; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS; MUCOSAL NECROSIS; OUTCOME ASSESSMENT; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME; ULCER; UNIVERSITY HOSPITAL;

EID: 34447650435     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)89434-6     Document Type: Article

References (28)

1. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-34.
2. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 2002;33:484-95.
3. de Schipper JP, Liem RS, van den Ingh HF, van der HE. Revision of gastrointestinal mesenchymal tumours with CD117. Eur J Surg Oncol 2004;30:959-62.
4. Demetri GD.Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer 2002;38 Suppl 5:S52-S59.
5. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68.
6. Ray-Coquard I, Le Cesne A, Michallet V, Boukovinas I, Ranchere D, Thiesse P, et al. Tumeurs stromales du tractus digestif: actualités 2003. Bull Cancer 2003;90:69-76.
7. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-65.
8. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 2003;54:3-24.
9. Emile JF, Theou N, Tabone S, Cortez A, Terrier P, Chaumette MT, et al. Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol 2004;2:597-605.
10. Balaton AJ, Coindre JM, Cvitkovic F. Tumeurs stromales digestives. Gastroenterol Clin Biol 2001;25:473-82.
11. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
12. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669-76.
13. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213-20.
14. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002;117:188-93.
15. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
16. Benoist S, Lecesne A. Homme de 55 ans qui présente une masse abdominale. J Chir (Paris) 2002;139:332-8.
17. Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, et al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol 2004;30:1098-103.
18. Cavaliere D, Griseri G, Venturino E, Schirru A, Cosce U, Caristo I, et al. Management of patients with gastrointestinal stromal tumors: experience from an Italian hospital. Tumori 2005;91:467-71.
19. Ozguc H, Yilmazlar T, Yerci O, Soylu R, Tumay V, Filiz G, et al. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg 2005;9:418-29.
20. DeMatteo RP, Heinrich MC, El Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 2002;33:466-77.
21. Bouillot JL, Bresler L, Fagniez PL, Samama G, Champault G, Parent Y. Exérèse laparoscopique des tumeurs sous-muqueuses bénignes de l'estomac. A propos de 65 cas. Gastroenterol Clin Biol 2003;27:272-6.
22. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215:68-77.
23. Blay JY, Landi B, Bonvalot S, Monges G, Ray-Coquard I, Duffaud F, et al. Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales (GIST). Bull Cancer 2005;92:907-18.
24. Clere F, Carola E, Halimi C, de Gramont A, Bonvalot S, Panis Y, et al. Actualités sur les tumeurs stromales gastro-intestinales : à partir de sept observations de tueurs malignes. Rev Med Interne 2002;23:499-507.
25. Abdulkader I, Cameselle-Teijeiro J, Gude F, Fraga M, Varela-Duran J, Barreiro F, et al. Predictors of malignant behaviour in gastrointestinal stromal tumours: a clinicopathological study of 34 cases. Eur J Surg 2002;168:288-96.
26. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160-5.
27. Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. Hum Pathol 1998;29:791-800.
28. Miettinen M, El Rifai W, Sobin HL, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002;33:478-83.